domingo, 13 de noviembre de 2016

Extended RAS Gene Mutation Testing in Metastatic Colorectal Carcinoma to Predict Response to Anti-Epidermal Growth Factor Receptor Monoclonal Antib... - PubMed - NCBI

Extended RAS Gene Mutation Testing in Metastatic Colorectal Carcinoma to Predict Response to Anti-Epidermal Growth Factor Receptor Monoclonal Antib... - PubMed - NCBI
 2016 Feb;12(2):180-1. doi: 10.1200/JOP.2015.007898. Epub 2015 Oct 6.

Extended RAS Gene Mutation Testing in Metastatic Colorectal Carcinoma to Predict Response to Anti-Epidermal Growth Factor Receptor Monoclonal Antibody Therapy: American Society of Clinical Oncology Provisional Clinical Opinion Update 2015 Summary.

PMID:
 
26443838
 
DOI:
 
10.1200/JOP.2015.007898
[PubMed - indexed for MEDLINE]

No hay comentarios:

Publicar un comentario